Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery. Read more about Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery.
Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer. Read more about Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer.
Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women. Read more about Ductal carcinoma in situ: knowledge of associated risks and prognosis among Latina and non-Latina white women.
The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care. Read more about The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care.
Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention. Read more about Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention.
A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer. Read more about A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer.
Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography. Read more about Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography.
Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer. Read more about Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer.
Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Read more about Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007.
Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Read more about Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review.
